The influx of computing, innovative treatments and artificial intelligence, in addition to the rising cost of healthcare and budget issues among others, are quickly changing the traditional models of this industry.

RHTLaw Asia’s lawyers possess a rare combination of legal expertise and deep knowledge of the business and regulatory environment that our clients operate in.

Our lawyers act for global pharmaceutical and healthcare groups, biotech, medtech and digital health companies as well as private equity and venture capital firms, government funds and investment banks that are investing and/or advising Healthcare & Life Sciences businesses.

We recognise the unique challenges our clients face and have a dedicated team that understands the key issues affecting the industry. Whether you are a start-up or a multinational company, the team is capable of assisting and providing solutions at different stages of the business lifecycle – from discovery and development through to patent litigation.